NM_001080449.3(DNA2):c.2546G>T (p.Gly849Val) AND Mitochondrial DNA deletion syndrome with progressive myopathy

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Mar 25, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001808985.1

Allele description [Variation Report for NM_001080449.3(DNA2):c.2546G>T (p.Gly849Val)]

NM_001080449.3(DNA2):c.2546G>T (p.Gly849Val)

Gene:

DNA2:DNA replication helicase/nuclease 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

10q21.3

Genomic location:

Preferred name:

NM_001080449.3(DNA2):c.2546G>T (p.Gly849Val)

HGVS:

NC_000010.11:g.68422376C>A
NG_034247.1:g.54598G>T
NM_001080449.3:c.2546G>TMANE SELECT
NP_001073918.2:p.Gly849Val
NC_000010.10:g.70182133C>A
NM_001080449.2:c.2546G>T
NR_102264.2:n.2520G>T

Protein change:

G849V

Links:

dbSNP: rs2133361857

NCBI 1000 Genomes Browser:

rs2133361857

Molecular consequence:

NM_001080449.3:c.2546G>T - missense variant - [Sequence Ontology: SO:0001583]
NR_102264.2:n.2520G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Mitochondrial DNA deletion syndrome with progressive myopathy
Synonyms:: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 6
Identifiers:: MONDO: MONDO:0014062; MedGen: C3554599; Orphanet: 352470; OMIM: 615156

Recent activity

Clear Turn Off Turn On

GabPNGHw13743784
GabPNGHw13743784

biosample

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002059295	Centogene AG - the Rare Disease Company	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Mar 25, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002059295

Centogene AG - the Rare Disease Company

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Mar 25, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Centogene AG - the Rare Disease Company, SCV002059295.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Dec 24, 2023

ClinVar

Relating variation to medicine